Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
2 clinical trials · Condition
◉ Watch Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
| Record | Firm | Date |
|---|---|---|
| A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies (NCT06708897) | Lomond Therapeutics Holdings, Inc. | 2025-04-08 |
| B-cell Chronic Lymphoid Malignancies Markers (NCT04952974) | University Hospital, Strasbourg, France | 2021-06-14 |
Track Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia automatically
Every clearance here is in the API, with alerts when new ones post.